In addition, inhibition of ASCT2 function has resulted in a decrease of glutamine uptake and suppression of tumour cell growth7–9, indicating the dominant contribution of ASCT2 for glutamine uptake in tumour cells and tumour growth. Here, SLC1A5 is linked to neoplasm.